Skip to main content
. 2022 Jun 27;11(13):3713. doi: 10.3390/jcm11133713

Table 1.

Baseline patient characteristics according to progression to severe disease *.

Clinical Conditions Total Non-Severe Cases (n = 145/156) Severe Cases *
(n = 11/156)
Fisher’s Exact Test p-Value
n n (%) n (%)
Sex
Male 102 93 (91.2) 9 (8.8) 0.332
Female 54 52 (96.3) 2 (3.7)
Age
<60 years old 108 100 (92.6) 8 (7.4) 1.000
60 and older 48 45 (93.8) 3 (6.3)
Signs of pulmonary involvement
O2 sat > 93% and CT ≤ 50% † 124 121 (97.6) 3 (2.4) <0.001
O2 sat ≤ 93% or CT > 50% 32 24 (75.0) 8 (25.0)
Obesity
No (BMI < 30 kg/m²) 75 74 (98.7) 1 (1.3) 0.010
Yes (BMI ≥ 30 kg/m²) 81 71 (87.7) 10 (12.3)
Diabetes
No 116 115 (99.1) 1 (0.9) <0.001
Yes 40 30 (75.0) 10 (25.0)
Asthma/COPD
No 153 142 (92.8) 11 (7.2) 1.000
Yes 3 3 (100.0) 0 (0.0)
Dyslipidemia
No 131 122 (93.1) 9 (6.9) 0.690
Yes 25 23 (92.0) 2 (8.0)
Coronary artery disease
No 153 142 (92.8) 11 (7.2) 1.000
Yes 3 3 (100.0) 0 (0.0)

BMI, body mass index; COPD, chronic obstructive pulmonary disease; CT, computed tomography; O2 sat, oxygen saturation on room air. * Modified World Health Organization (WHO) Ordinal Scale for Clinical Improvement scores of 6–8. † Extent of lung involvement on initial chest CT scan estimated by visual assessment performed by a radiologist.